Loading market dashboard

Financials in CAD. Standardized financial statements.
A compact view of how Aequus Pharmaceuticals Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $584,237 | $254,896 | $1.38M | $2.71M | $2.59M | $1.63M | $1.41M | $1.14M | $701,633 | $0 |
| Revenue Growth? | +129.2% | -81.5% | -49.2% | +4.7% | +58.8% | +15.8% | +23.8% | +62.4% | 0.0% | 0.0% |
| Cost of Revenue? | $251,934 | $111,234 | $233,390 | $25,779 | $0 | $0 | $0 | $0 | $0 | $86,778 |
| Gross Profit? | $199,975 | $143,662 | $1.15M | $2.69M | $2.59M | $1.63M | $1.41M | $1.14M | $701,633 | -$86,778 |
| Gross Margin? | +34.2% | +56.4% | +83.1% | +99.1% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | 0.0% |
| Operating Expenses? | $2.46M | $2.96M | $3.64M | $4.06M | $3.12M | $3.85M | $4.22M | $5.05M | $5.57M | $5.06M |
| Operating Income? | -$2.13M | -$2.82M | -$2.50M | -$1.35M | -$521,570 | -$2.21M | -$2.81M | -$3.93M | $4.86M | $5.06M |
| EBITDA? | -$1.79M | -$2.68M | -$2.87M | -$1.23M | -$314,796 | -$2.38M | -$2.62M | -$3.70M | -$4.69M | -$4.97M |
| Income Before Tax | -$2.18M | -$2.96M | -$3.21M | -$1.81M | -$1.05M | -$3.11M | -$2.80M | -$3.88M | -$4.86M | -$5.01M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$4,289 | -$30,104 | -$50,721 | -$43,745 |
| Net Income? | -$2.18M | -$2.96M | -$3.21M | -$1.81M | -$1.05M | -$3.11M | -$2.80M | -$3.88M | -$4.81M | -$5.01M |
| EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.04 | $-0.04 | $-0.06 | $-0.10 | $-0.15 |
| Diluted EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.04 | $-0.04 | $-0.06 | $-0.10 | $-0.15 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality